Inventurus Knowledge Solutions is currently trading at Rs. 1344.60, up by 22.20 points or 1.68% from its previous closing of Rs. 1322.40 on the BSE.

The scrip opened at Rs. 1348.70 and has touched a high and low of Rs. 1362.85 and Rs. 1300.55 respectively. So far 25230 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1875.25 on 17-Jun-2025 and a 52 week low of Rs. 1226.15 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 1371.05 and Rs. 1262.35 respectively. The current market cap of the company is Rs. 22941.05 crore.

The promoters holding in the company stood at 63.72%, while Institutions and Non-Institutions held 13.62% and 22.66% respectively.

Inventurus Knowledge Solutions’ brand -- IKS Health has expanded strategic partnership with Certilytics, Inc., an innovator in AI-driven healthcare intelligence. The new collaboration is designed to bridge the historic divide between payers and providers by turning predictive insights into safe, coordinated clinical actions.

As healthcare enters the era of agentic AI, the industry is moving beyond systems of intelligence that simply identify risks to systems of action that execute the work. By integrating Certilytics’ BrainstormAI Studio and CertHLM with the IKS Health Agentic Care Enablement Platform, the companies are creating a premier ecosystem where AI agents manage complex tasks, such as prior authorization and patient outreach, under the continuous oversight of human expertise.

This partnership continues an ongoing collaboration based on the shared vision of bridging the payerprovider gap through agentic AI, human oversight, and unified action.

Inventurus Knowledge Solutions is a technology-enabled healthcare solutions provider and offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. It offers a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care.